51 related articles for article (PubMed ID: 15539084)
1. Visualization of 5T33 myeloma cells in the C57BL/KaLwRij mouse: establishment of a new syngeneic murine model of multiple myeloma.
Alici E; Konstantinidis KV; Aints A; Dilber MS; Abedi-Valugerdi M
Exp Hematol; 2004 Nov; 32(11):1064-72. PubMed ID: 15539084
[TBL] [Abstract][Full Text] [Related]
2. Age matters: Young T lymphocytes offer better protection from myeloma proliferation.
Glick AF; Song YS; Hwang B; Lillvis J; Zanzonico P; Fuchs C; Pearse RN; Szabo P; Weksler ME
Immun Ageing; 2013 Feb; 10(1):5. PubMed ID: 23419047
[TBL] [Abstract][Full Text] [Related]
3. An Improved Animal Model of Multiple Myeloma Bone Disease.
Mehdi SH; Morris CA; Lee JA; Yoon D
Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503090
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the role of Samsn1 loss in multiple myeloma development.
Friend NL; Hewett DR; Panagopoulos V; Noll JE; Vandyke K; Mrozik KM; Fitter S; Zannettino ACW
FASEB Bioadv; 2020 Sep; 2(9):554-572. PubMed ID: 32923989
[TBL] [Abstract][Full Text] [Related]
5. The Synthetic Collagen-Binding Peptide NIPEP-OSS Delays Mouse Myeloma Progression.
Mehdi SH; Gentry AC; Lee JY; Chung CP; Yoon D
Cancers (Basel); 2023 Apr; 15(9):. PubMed ID: 37173940
[TBL] [Abstract][Full Text] [Related]
6. Whole Genome Sequence of Multiple Myeloma-Prone C57BL/KaLwRij Mouse Strain Suggests the Origin of Disease Involves Multiple Cell Types.
Amend SR; Wilson WC; Chu L; Lu L; Liu P; Serie D; Su X; Xu Y; Wang D; Gramolini A; Wen XY; O'Neal J; Hurchla M; Vachon CM; Colditz G; Vij R; Weilbaecher KN; Tomasson MH
PLoS One; 2015; 10(5):e0127828. PubMed ID: 26020268
[TBL] [Abstract][Full Text] [Related]
7. The use of animal models in multiple myeloma.
Libouban H
Morphologie; 2015 Jun; 99(325):63-72. PubMed ID: 25898798
[TBL] [Abstract][Full Text] [Related]
8. A murine model of human myeloma bone disease.
Garrett IR; Dallas S; Radl J; Mundy GR
Bone; 1997 Jun; 20(6):515-20. PubMed ID: 9177864
[TBL] [Abstract][Full Text] [Related]
9. Detection of myeloma in skeleton of mice by whole-body optical fluorescence imaging.
Oyajobi BO; Muñoz S; Kakonen R; Williams PJ; Gupta A; Wideman CL; Story B; Grubbs B; Armstrong A; Dougall WC; Garrett IR; Mundy GR
Mol Cancer Ther; 2007 Jun; 6(6):1701-8. PubMed ID: 17541032
[TBL] [Abstract][Full Text] [Related]
10. The genetic landscape of 5T models for multiple myeloma.
Maes K; Boeckx B; Vlummens P; De Veirman K; Menu E; Vanderkerken K; Lambrechts D; De Bruyne E
Sci Rep; 2018 Oct; 8(1):15030. PubMed ID: 30301958
[TBL] [Abstract][Full Text] [Related]
11. LTe2 induces cell apoptosis in multiple myeloma by suppressing AKT phosphorylation at Thr308 and Ser473.
Zhang Y; Qian J; Jiang M; Yang S; Zhou L; Zhang Q; Lin L; Yang Y
Front Oncol; 2023; 13():1269670. PubMed ID: 37781194
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of PI3K Class IA Kinases Using GDC-0941 Overcomes Cytoprotection of Multiple Myeloma Cells in the Osteoclastic Bone Marrow Microenvironment Enhancing the Efficacy of Current Clinical Therapeutics.
Kikuchi H; Amofa E; Mcenery M; Schey SA; Ramasamy K; Farzaneh F; Calle Y
Cancers (Basel); 2023 Jan; 15(2):. PubMed ID: 36672411
[TBL] [Abstract][Full Text] [Related]
13. Pathogenesis and treatment of multiple myeloma.
Yang P; Qu Y; Wang M; Chu B; Chen W; Zheng Y; Niu T; Qian Z
MedComm (2020); 2022 Jun; 3(2):e146. PubMed ID: 35665368
[TBL] [Abstract][Full Text] [Related]
14. Adhesion molecules in multiple myeloma oncogenesis and targeted therapy.
Bou Zerdan M; Nasr L; Kassab J; Saba L; Ghossein M; Yaghi M; Dominguez B; Chaulagain CP
Int J Hematol Oncol; 2022 Apr; 11(2):IJH39. PubMed ID: 35663420
[TBL] [Abstract][Full Text] [Related]
15. Laboratory Mice - A Driving Force in Immunopathology and Immunotherapy Studies of Human Multiple Myeloma.
Pisano M; Cheng Y; Sun F; Dhakal B; D'Souza A; Chhabra S; Knight JM; Rao S; Zhan F; Hari P; Janz S
Front Immunol; 2021; 12():667054. PubMed ID: 34149703
[TBL] [Abstract][Full Text] [Related]
16. Host-Derived Matrix Metalloproteinase-13 Activity Promotes Multiple Myeloma-Induced Osteolysis and Reduces Overall Survival.
Lo CH; Shay G; McGuire JJ; Li T; Shain KH; Choi JY; Fuerst R; Roush WR; Knapinska AM; Fields GB; Lynch CC
Cancer Res; 2021 May; 81(9):2415-2428. PubMed ID: 33526510
[TBL] [Abstract][Full Text] [Related]
17. Nanoparticle-based Cell Trackers for Biomedical Applications.
Ni JS; Li Y; Yue W; Liu B; Li K
Theranostics; 2020; 10(4):1923-1947. PubMed ID: 32042345
[TBL] [Abstract][Full Text] [Related]
18. Targeting MK2 Is a Novel Approach to Interfere in Multiple Myeloma.
Guo M; Sun D; Fan Z; Yuan Y; Shao M; Hou J; Zhu Y; Wei R; Zhu Y; Qian J; Li F; Yang Y; Gu C
Front Oncol; 2019; 9():722. PubMed ID: 31440466
[TBL] [Abstract][Full Text] [Related]
19. Bone marker gene expression in calvarial bones: different bone microenvironments.
Al-Amer O
J Biol Res (Thessalon); 2017 Dec; 24():9. PubMed ID: 28523251
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
